Skip to main content

and
  1. No Access

    Article

    Quality of life in men with metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone: a systematic review and meta-analysis

    Enzalutamide and abiraterone acetate plus prednisone (AAP) have similar efficacy in metastatic castration-resistant prostate cancer (mCRPC), but different mechanisms of action. The aim was to compare patient-r...

    Klara Kvorning Ternov, Alexander Bjørneboe Nolsøe in Prostate Cancer and Prostatic Diseases (2021)